FDA clears MRI-compatible cochlear implant June 17, 2019 -- Cochlear Limited has received U.S. Food and Drug Administration (FDA) clearance for use of its Nucleus Profile Plus cochlear implant in 1.5- and 3-tesla MRI systems.
Blue Earth highlights SNMMI 2019 presentations June 14, 2019 -- Molecular imaging firm Blue Earth Diagnostics is touting 16 presentations involving its Axumin PET radiopharmaceutical and "radiohybrid" prostate-specific membrane antigen imaging agent at next week's Society of Nuclear Medicine and Molecular Imaging (SNMMI) annual meeting.
Navidea readies public stock offering June 14, 2019 -- Radiopharmaceutical developer Navidea Biopharmaceuticals is planning to raise $6 million in a new public offering of its common stock.
Venture capitalist: Radiologists are 'toast' due to AI June 14, 2019 -- Sun Microsystems founder and venture capitalist Vinod Khosla said Wednesday that artificial intelligence (AI) will advance so far that "any radiologist who continues to practice in 10 years will be killing patients every day," according to an article on TechCrunch.
Cianna points to new APBI research June 14, 2019 -- Breast tumor localization and breast conservation therapy technology developer Cianna Medical said that a study being presented June 14 at the American Brachytherapy Society annual meeting in Miami demonstrates the feasibility of an ultra-hypofractionated accelerated partial breast irradiation (APBI) regimen.
Fujifilm debuts breast cancer awareness campaign June 14, 2019 -- Fujifilm Medical Systems USA has launched Aspire to Be Fearless, a nationwide awareness campaign aimed at improving access to breast health education and mammography screening services.
Materialise wins FDA nod for Mimics Enlight June 13, 2019 -- 3D printing software developer Materialise has garnered U.S. Food and Drug Administration (FDA) clearance for its Mimics Enlight cardiovascular planning software.
ANSTO licensed to fully supply Mo-99 June 12, 2019 -- The Australian Nuclear Science and Technology Organization (ANSTO) has received a license to begin full production of molybdenum-99 (Mo-99) at its new nuclear facility.